PACAP Orchestration of Stress-related Responses in Neural Circuits

Overview

Journal Peptides

Specialty Biochemistry

Date 2021 Apr 18

PMID 33865930

Citations 18

Authors

Melissa N Boucher

Victor May

Karen M Braas

Sayamwong E Hammack

Affiliations

Soon will be listed here.

Abstract

Pituitary adenylate cyclase activating polypeptide (PACAP) is a pleiotropic polypeptide that can activate G protein-coupled PAC1, VPAC1, and VPAC2 receptors, and has been implicated in stress signaling. PACAP and its receptors are widely distributed throughout the nervous system and other tissues and can have a multitude of effects. Human and animal studies suggest that PACAP plays a role responding to a variety of threats and stressors. Here we review the roles of PACAP in several regions of the central nervous system (CNS) as they relate to several behavioral functions. For example, in the bed nucleus of the stria terminalis (BNST), PACAP is upregulated following chronic stress and may drive anxiety-like behavior. PACAP can also influence both the consolidation and expression of fear memories, as demonstrated by studies in several fear-related areas, such as the amygdala, hippocampus, and prefrontal cortex. PACAP can also mediate the emotional component of pain, as PACAP in the central nucleus of the amygdala (CeA) is able to decrease pain sensitivity thresholds. Outside of the central nervous system, PACAP may drive glucocorticoid release via enhanced hypothalamic-pituitary-adrenal axis activity and may participate in infection-induced stress responses. Together, this suggests that PACAP exerts effects on many stress-related systems and may be an important driver of emotional behavior.

Citing Articles

Pituitary adenylate cyclase-activating polypeptide plays a role in neuropsychiatric and substance use disorders: sex-specific perspective.

Van Doorn C, Zelows M, Jaramillo A Front Neurosci. 2025; 19:1545810.

PMID: 39975969 PMC: 11835941. DOI: 10.3389/fnins.2025.1545810.

Administration of a Selective Antagonist for Pituitary Adenylate Cyclase-Activating Polypeptide Receptor in the Hippocampus Causes Anxiolytic Effects in the Male Rat.

Sato K, Chiba S, Hatakeyama T, Matsuwaki T, Watanabe G, Kawaguchi M Neuropsychopharmacol Rep. 2024; 45(1):e12514.

PMID: 39723441 PMC: 11669842. DOI: 10.1002/npr2.12514.

Basolateral amygdala oscillations enable fear learning in a biophysical model.

Cattani A, Arnold D, McCarthy M, Kopell N Elife. 2024; 12.

PMID: 39590510 PMC: 11594530. DOI: 10.7554/eLife.89519.

PACAP regulates neuroendocrine and behavioral stress responses via CRF-containing neurons of the rat hypothalamic paraventricular nucleus.

Ebner K, Fontebasso V, Ferro F, Singewald N, Hannibal J Neuropsychopharmacology. 2024; 50(3):519-530.

PMID: 39472527 PMC: 11735793. DOI: 10.1038/s41386-024-02016-9.

Brain RFamide Neuropeptides in Stress-Related Psychopathologies.

Kovacs A, Szabo E, Laszlo K, Kertes E, Zagoracz O, Mintal K Cells. 2024; 13(13.

PMID: 38994950 PMC: 11240450. DOI: 10.3390/cells13131097.

References

Lehmann M, Mustafa T, Eiden A, Herkenham M, Eiden L . PACAP-deficient mice show attenuated corticosterone secretion and fail to develop depressive behavior during chronic social defeat stress. Psychoneuroendocrinology. 2012; 38(5):702-15. PMC: 3652373. DOI: 10.1016/j.psyneuen.2012.09.006. View

Waschek J . Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration. Dev Neurosci. 2002; 24(1):14-23. DOI: 10.1159/000064942. View

Missig G, Mei L, Vizzard M, Braas K, Waschek J, Ressler K . Parabrachial Pituitary Adenylate Cyclase-Activating Polypeptide Activation of Amygdala Endosomal Extracellular Signal-Regulated Kinase Signaling Regulates the Emotional Component of Pain. Biol Psychiatry. 2017; 81(8):671-682. PMC: 5332340. DOI: 10.1016/j.biopsych.2016.08.025. View

Jaworski D, Proctor M . Developmental regulation of pituitary adenylate cyclase-activating polypeptide and PAC(1) receptor mRNA expression in the rat central nervous system. Brain Res Dev Brain Res. 2000; 120(1):27-39. DOI: 10.1016/s0165-3806(99)00192-3. View

Legradi G, Das M, Giunta B, Hirani K, Mitchell E, Diamond D . Microinfusion of pituitary adenylate cyclase-activating polypeptide into the central nucleus of amygdala of the rat produces a shift from an active to passive mode of coping in the shock-probe fear/defensive burying test. Neural Plast. 2007; 2007:79102. PMC: 1906870. DOI: 10.1155/2007/79102. View

Stroth N, Kuri B, Mustafa T, Chan S, Smith C, Eiden L . PACAP controls adrenomedullary catecholamine secretion and expression of catecholamine biosynthetic enzymes at high splanchnic nerve firing rates characteristic of stress transduction in male mice. Endocrinology. 2012; 154(1):330-9. PMC: 3529367. DOI: 10.1210/en.2012-1829. View

Koves K, Arimura A, Gorcs T, Somogyvari-Vigh A . Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Neuroendocrinology. 1991; 54(2):159-69. DOI: 10.1159/000125864. View

Torrisi S, OConnell K, Davis A, Reynolds R, Balderston N, Fudge J . Resting state connectivity of the bed nucleus of the stria terminalis at ultra-high field. Hum Brain Mapp. 2015; 36(10):4076-88. PMC: 4583367. DOI: 10.1002/hbm.22899. View

Wei P, Keller C, Li L . Neuropeptides in gut-brain axis and their influence on host immunity and stress. Comput Struct Biotechnol J. 2020; 18:843-851. PMC: 7160382. DOI: 10.1016/j.csbj.2020.02.018. View

10.

Waddell J, Morris R, Bouton M . Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear. Behav Neurosci. 2006; 120(2):324-36. DOI: 10.1037/0735-7044.120.2.324. View

11.

Harmar A, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna J . Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol. 2012; 166(1):4-17. PMC: 3415633. DOI: 10.1111/j.1476-5381.2012.01871.x. View

12.

Miyata A, Jiang L, Dahl R, Kitada C, Kubo K, Fujino M . Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun. 1990; 170(2):643-8. DOI: 10.1016/0006-291x(90)92140-u. View

13.

Missig G, Roman C, Vizzard M, Braas K, Hammack S, May V . Parabrachial nucleus (PBn) pituitary adenylate cyclase activating polypeptide (PACAP) signaling in the amygdala: implication for the sensory and behavioral effects of pain. Neuropharmacology. 2014; 86:38-48. PMC: 4322675. DOI: 10.1016/j.neuropharm.2014.06.022. View

14.

Thiele T, Roitman M, Bernstein I . c-Fos induction in rat brainstem in response to ethanol- and lithium chloride-induced conditioned taste aversions. Alcohol Clin Exp Res. 1996; 20(6):1023-8. DOI: 10.1111/j.1530-0277.1996.tb01941.x. View

15.

Tonshoff C, Hemmick L, Evinger M . Pituitary adenylate cyclase activating polypeptide (PACAP) regulates expression of catecholamine biosynthetic enzyme genes in bovine adrenal chromaffin cells. J Mol Neurosci. 1998; 9(2):127-40. DOI: 10.1007/BF02736856. View

16.

Foster J, McVey Neufeld K . Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013; 36(5):305-12. DOI: 10.1016/j.tins.2013.01.005. View

17.

Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy D, Kitada C . Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology. 1991; 129(5):2787-9. DOI: 10.1210/endo-129-5-2787. View

18.

Roman C, Lezak K, Hartsock M, Falls W, Braas K, Howard A . PAC1 receptor antagonism in the bed nucleus of the stria terminalis (BNST) attenuates the endocrine and behavioral consequences of chronic stress. Psychoneuroendocrinology. 2014; 47:151-65. PMC: 4342758. DOI: 10.1016/j.psyneuen.2014.05.014. View

19.

Hashimoto H, Nogi H, Mori K, Ohishi H, Shigemoto R, Yamamoto K . Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: an in situ hybridization study. J Comp Neurol. 1996; 371(4):567-77. DOI: 10.1002/(SICI)1096-9861(19960805)371:4<567::AID-CNE6>3.0.CO;2-2. View

20.

Dore R, Iemolo A, Smith K, Wang X, Cottone P, Sabino V . CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP. Neuropsychopharmacology. 2013; 38(11):2160-9. PMC: 3773665. DOI: 10.1038/npp.2013.113. View